TECL vs XBI
Direxion Daily Technology Bull 3X ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.87% for TECL.
- • XBI pays a higher dividend yield (0.35%).
Side-by-side metrics
| Metric | TECL | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.87% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.17% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $5.07B | $10.92B |
YTD return | 23.12% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 4.94 | 1.01 |
P/E ratio | 26.32 | — |
Last price | $156.80 | $156.41 |
Inception | — | — |
Issuer | Direxion | State Street |
TECL top holdings
| AAPL | Apple Inc | 3.54% |
| NVDA | NVIDIA Corp | 3.48% |
| MSFT | Microsoft Corp | 2.73% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About TECL
TECL (Direxion Daily Technology Bull 3X ETF) is 3x daily performance of the S&P tech sector. Managed by Direxion, the fund carries $5.1B in assets under management, an expense ratio of 0.87%, a dividend yield of 0.17%. Its largest holding is Apple Inc (AAPL), which represents 3.5% of the portfolio. Technology is the fund's largest sector exposure at 100.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.